Katie Topley
(hi/ei)
BSc (Hons), MSc
Timau a rolau for Katie Topley
Swyddog Biobanc Prifysgol Caerdydd
Biofeddygol a Gwyddorau Bywyd
Cyhoeddiad
2025
- Dolton, G. et al., 2025. MHC-related protein 1-restricted recognition of cancer via a semi-invariant TCR-α chain.. The Journal of Clinical Investigation 135 (1) e181895. (10.1172/JCI181895)
2024
- Dolton, G. et al. 2024. HLA A*24:02-restricted T-cell receptors cross recognise bacterial and preproinsulin peptides in type 1 diabetes. Journal of Clinical Investigation 134 (18) e164535. (10.1172/JCI164535)
2023
- Dolton, G. et al. 2023. Targeting of multiple tumor-associated antigens by individual T cell receptors during successful cancer immunotherapy. Cell 186 (16), pp.3333-3349. E27. (10.1016/j.cell.2023.06.020)
2022
- Dolton, G. et al. 2022. Emergence of immune escape at dominant SARS-CoV-2 killer T cell epitope. Cell 185 (16), pp.2936-2951. (10.1016/j.cell.2022.07.002)
Erthyglau
- Dolton, G. et al., 2025. MHC-related protein 1-restricted recognition of cancer via a semi-invariant TCR-α chain.. The Journal of Clinical Investigation 135 (1) e181895. (10.1172/JCI181895)
- Dolton, G. et al. 2024. HLA A*24:02-restricted T-cell receptors cross recognise bacterial and preproinsulin peptides in type 1 diabetes. Journal of Clinical Investigation 134 (18) e164535. (10.1172/JCI164535)
- Dolton, G. et al. 2023. Targeting of multiple tumor-associated antigens by individual T cell receptors during successful cancer immunotherapy. Cell 186 (16), pp.3333-3349. E27. (10.1016/j.cell.2023.06.020)
- Dolton, G. et al. 2022. Emergence of immune escape at dominant SARS-CoV-2 killer T cell epitope. Cell 185 (16), pp.2936-2951. (10.1016/j.cell.2022.07.002)